Reviews from the Academic Research Consortium 3 – Coronary Interventions

Published: 08 November 2023

  • Views:

    Views Icon 1276
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


The Academic Research Consortium (ARC) is an international collaborative forum across medical device stakeholders that includes academics, clinical trialists, regulatory bodies and industry.


The purpose of the ARC is to create a dynamic, transparent and collaborative forum for stakeholders to develop consensus definitions and standard nomenclature in pivotal clinical trials of medical devices and to disseminate such definitions and recommended processes into the public domain.


The ARC-2 initiative (2018) updated the widely used ARC-1 pragmatic consensus definitions for coronary device trials (2007) to incorporate experience gained with the initial definitions, interim recommendations from professional societies, and the expansion of clinical trials to include more complex patient/lesion subsets and novel devices. Coronary research definitions continue to evolve and the ARC-3 initiative is ongoing.


This webinar series addresses the hot topics in interventional cardiology, providing state-of-the-art reviews by global leaders from all over the world. Presentations were prepared for the ARC-3 in-person meeting earlier in 2023 and deal with historical and future perspectives. 


Learn more about ARC at:

This webinar series is supported by

Key Learning Objectives

  • Discover the existing data, unmet needs, and practical considerations about personalisation of revascularization strategies, either through coronary artery bypass grafting or percutaneous coronary interventions
  • Witness the unprecedented evolution of wire-based physiology, angio-based physiology, and CT-based physiology, for assessment of the severity and clinical relevance of coronary stenosis
  • Explore the strength of coronary imaging data based on ongoing and completed studies in America, Asia, and Europe
  • Learn about the largest studies in coronary physiology and coronary imaging that will determine the future indication and recommendation classes in clinical practice guideline
  • Immerse into the possibilities of registry-based research through the eyes of some of the most notable experts on this topic globally

Target Audience

  • Interventional Cardiologists

More from this programme

Part 1

State-of-The-Art in Coronary Research: Imaging Trials

Part 2

State-of-The-Art in Coronary Research: Physiology Trials

Part 3

State-of-The-Art in Registry-based Research: Imaging and Physiology

Part 4

State-of-The-Art in Coronary Research: CABG vs. PCI Trials

Faculty Biographies

Duk-Woo Park

Duk-Woo Park

Professor of Medicine

Prof Duk-Woo Park is Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine.

Prof Park has a particular interest in revascularization strategy (PCI vs. CABG for multivessel and left main disease), antiplatelet/antithrombotic strategey, transcatheter valve interventions (TAVR), major clinical trials or registries studies (drugs, stents, revascularization strategy), biomarkers, and medical statistics. 

View full profile
Adrian P Banning

Adrian P Banning

Consultant Cardiologist

Prof Adrian Banning is a Consultant Cardiologist, specialising in percutaneous coronary intervention. He works as a Consultant in interventional and general cardiology and is one of the founder members of the Oxford Private Heart and Lung Centre at Nuffield Health Oxford at The Manor Hospital.

He is recognised as one of the UK’s top interventional cardiologists and until recently he was President of the British Cardiac Intervention Society. He performs more than 250 coronary intervention procedures every year and he is an expert in TAVI –implantation of a new aortic valve through a keyhole incision and performs >150 of these TAVI procedures each year.

Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.

View full profile
Mario FL Gaudino

Mario FL Gaudino

Professor in Cardiothoracic Surgery

Dr. Mario Gaudino is the Stephen and Suzanne Weiss Professor in the Department of Cardiothoracic Surgery at NewYork-Presbyterian/Weill Cornell Medicine. In addition, he serves as the Assistant Dean for Clinical Trials, Director for the JCTO, and the Director of Translational and Clinical Research for the Department of CT Surgery. Throughout his career, he has published more than 600 peer-reviewed manuscripts in high impact journals as well as numerous book chapters. He is currently the lead investigator of several international, randomized trials: ROMA, ROMA:Women, STICH3C, ODIN, PALACS, and EPIC. As a known advocate for scientific integrity and surgical quality, Dr. Gaudino is often called upon to serve on guideline writing committees to help set standards for cardiac surgery. Along with his expert knowledge in CABG including the use of multiple arterial grafting, he also specializes in structural heart disease, valvular dysfunction and complex aortic procedures.

View full profile


You must be to comment. If you are not registered, you can register here.